Immune Netw.  2002 Mar;2(1):6-11. 10.4110/in.2002.2.1.6.

Allicin Reduces Adhesion Molecules and NO Production Induced by gamma irradiation in Human Endothelial Cells

Affiliations
  • 1Division of Immunopharmacology, College of Pharmacy, Sungkyunkwan University, Suwon, Korea. snpyo@skku.ac.kr
  • 2Department of Radiation Oncology, Korea Cancer Center Hospital, Seoul, Korea.

Abstract

BACKGROUND: Inflammation is a frequent reaction following therapeutic irradiation. Since the upregulation of adhesion molecules on endothelial cell surface is known to be associated with inflammation, the expression of adhesion molecules is an important therapeutic target.
METHODS
Treatment of human umbilical endothelial cells (HUVECs) with gamma irradiation (gamma R) induces the expression of adhesion proteins such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin. Changes in the expression of these proteins on gamma irradiated HUVECs which had been treated previously with allicin were measured by ELISA.
RESULTS
In the present study, we demonstrate that allicin inhibits the gamma R induced expression of ICAM-1, VCAM-1, and E-selectin on HUVEC in a dose-dependent manner. Allicin was also found to inhibit thegamma R induced production of nitric oxide (NO).
CONCLUSION
These data suggest that allicin has a therapeutic potential for the treatment of various inflammatory disorders associated with increase numbers of endothelial leukocyte adhesion molecules.

Keyword

Allicin; gamma irradiation; endothelial cells; ICAM-1; VCAM-1; E-selectin; NO

MeSH Terms

Cell Adhesion Molecules
E-Selectin
Endothelial Cells*
Enzyme-Linked Immunosorbent Assay
Humans*
Inflammation
Intercellular Adhesion Molecule-1
Nitric Oxide
Up-Regulation
Vascular Cell Adhesion Molecule-1
Cell Adhesion Molecules
E-Selectin
Intercellular Adhesion Molecule-1
Nitric Oxide
Vascular Cell Adhesion Molecule-1
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr